Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Battelle’s CBRNE Defense Leader Speaks at CBRNe Convergence

by Global Biodefense Staff
October 29, 2014
Battelle Resource Effective BioIdentification System (REBS)
Battelle Resource Effective BioIdentification System (REBS)

As health and policy leaders wrestle with how to respond to the deadly Ebola outbreak, a leading Battelle expert in the detection of airborne biological threats will describe the need for new biodetection technologies to homeland security and defense experts gathered at CBRNe Convergence.

Matthew Shaw, vice president and general manager of CBRNE Defense at Battelle, will address the global conference today. Battelle, the world’s largest independent R&D nonprofit, has helped government agencies and industry solve some of the most complex Chemical, Biological, Radiological, Nuclear & Explosive (CBRNE) defense challenges for the past several decades.

Battelle has been investing in state-of-the-art biodetection technology to enable effective detection and identification at significantly reduced operational costs as compared to current technology. Currently, Battelle is working to verify that an aerosolized version of the Ebola virus, and other infectious agents like the Enterovirus D-68, could be detected rapidly and inexpensively using this technology.

“The current Ebola outbreak, as well as the Enterovirus D-68 outbreak responsible for many deaths, demonstrate the need for us to step up our public health preparedness and response protocols, as well as our detection capabilities,” Shaw said. Shaw will trace Battelle’s approach to biological hazard detection from the first Gulf War to next-generation technologies that can deploy more safely, quickly and less expensively.

“You hear a lot of concern over viruses becoming ‘aerosolized’ because inhalation is the easiest way for an infection to spread,” Shaw said. “That’s why it’s critical to be able to recognize the presence of an infectious bioaerosol as quickly as possible, preferably before people start getting sick. Early detection and rapid medical diagnosis are our best lines of defense.”

Battelle has a long history of helping the Department of Defense develop bioaerosol detection systems. In the 1990s, Battelle helped the U.S. Army identify and develop off-the-shelf instruments and technology for use in the manually-intensive “lab-on-a-truck” Biological Integrated Detection System (BIDS). Then, in response to the Army’s call for a reliable, automated system to detect and identify biological threats, Battelle spearheaded development of the military’s current automated biodetection system, the Joint Biological Point Detection System (JBPDS).

Today, there are hundreds of these units deployed worldwide, from Navy ships to the Stryker NBCRV and the M31A2 Biological Integrated Detection System, each containing bio-suite components manufactured by Battelle.

Currently, Battelle is selling its Resource Effective BioIdentification System (REBS), which is an automated, reagentless, and effective biodetection system with very low operational costs—at about $1 per day—as compared to other systems.

Source: Battelle press release, adapted. Battelle is a supporting sponsor of Global Biodefense.

Tags: BattelleChemical DetectionCollective ProtectionEvents

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC